Meningococcal vaccine found to be safe and effective for infants in sub-Saharan Africa, study suggests

Published on March 12, 2025

Researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub-Saharan Africa is safe and effective for use in young children beginning at 9 months of age. This study provided evidence that formed the basis for the World Health Organization's (WHO) decision last year to recommend the pentavalent Men5CV meningitis vaccine for infants ages 9 months and older.

Continue reading on website
Other news

Breakthrough in next-generation polio vaccines

March 11, 2025
A more affordable, lower-risk polio vaccine is on the horizon, research has found.

The relationship between gut microbiota, immunoglobulin A, and vaccine efficacy

March 13, 2025
A study has established the importance of immunoglobulin A, an antibody that is part of the immune system, in generating a response to pneumonia vaccines. Researchers have found that the absence of this antibody leads to an overgrowth of gut microbiota, triggering an excessive and sustained immune system response, which ultimately becomes exhausted and fails to respond effectively to vaccines.